Free Trial

Canopy Growth (TSE:WEED) Sets New 1-Year Low - Time to Sell?

Canopy Growth logo with Medical background

Canopy Growth Corp (TSE:WEED - Get Free Report) hit a new 52-week low during mid-day trading on Monday . The company traded as low as C$1.81 and last traded at C$1.82, with a volume of 1131063 shares traded. The stock had previously closed at C$2.03.

Wall Street Analyst Weigh In

WEED has been the subject of a number of recent analyst reports. Canaccord Genuity Group lowered their price objective on Canopy Growth from C$2.50 to C$1.50 and set a "sell" rating for the company in a research note on Monday, February 10th. ATB Capital reduced their price objective on Canopy Growth from C$4.00 to C$3.20 and set an "underperform" rating on the stock in a research note on Monday, February 10th. Four equities research analysts have rated the stock with a sell rating and one has assigned a hold rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of "Reduce" and a consensus target price of C$5.64.

Read Our Latest Analysis on WEED

Canopy Growth Stock Performance

The firm has a market cap of C$289.56 million, a price-to-earnings ratio of -0.26, a PEG ratio of -0.01 and a beta of 1.79. The stock's fifty day moving average is C$3.05 and its two-hundred day moving average is C$5.08. The company has a debt-to-equity ratio of 120.38, a quick ratio of 2.32 and a current ratio of 1.39.

About Canopy Growth

(Get Free Report)

Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, CraftGrow, and Foria brand names.

Recommended Stories

Should You Invest $1,000 in Canopy Growth Right Now?

Before you consider Canopy Growth, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Canopy Growth wasn't on the list.

While Canopy Growth currently has a Strong Sell rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Tesla Sinks on Musk Drama—Bounce or Bigger Crash?
3 AI Stocks to Watch After NVIDIA’s Dip
Congress Cashes In on Stocks—Here’s How You Can Too!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines